X23-10-ZQ1027 |
EGFR-HER2 inhibitor AEE788, Purity ≥98%
|
|
X23-10-ZQ1028 |
EGFR-HER2 inhibitor Tyrphostin AG 879, Purity ≥98%
|
|
X23-10-ZQ1029 |
EGFR-HER2 inhibitor AST-6, Purity ≥98%
|
|
X23-10-ZQ1030 |
EGFR-HER2 inhibitor AZD8931, Purity ≥98%
|
|
X23-10-ZQ1031 |
EGFR-HER2 inhibitor BIBW2992, Purity ≥98%
|
|
X23-10-ZQ1033 |
EGFR-HER2 inhibitor Canertinib, Purity ≥98%
|
|
X23-10-ZQ1034 |
EGFR-HER2 inhibitor CP-724714, Purity ≥98%
|
|
X23-10-ZQ1035 |
EGFR-HER2 inhibitor Erlotinib HCl, Purity ≥98%
|
|
X23-10-ZQ1036 |
EGFR-HER2 inhibitor Gefitinib, Purity ≥98%
|
|
X23-10-ZQ1038 |
EGFR-HER2 inhibitor Lapatinib ditosylate, Purity ≥98%
|
|
X23-10-ZQ1039 |
EGFR-HER2 inhibitor Mubritinib, Purity ≥98%
|
|
X23-10-ZQ1040 |
EGFR-HER2 inhibitor Neratinib, Purity ≥98%
|
|
X23-10-ZQ1041 |
EGFR-HER2 inhibitor OSI-420, Purity ≥98%
|
|
X23-10-ZQ1042 |
EGFR-HER2 inhibitor PD153035, Purity ≥98%
|
|
X23-10-ZQ1043 |
EGFR-HER2 inhibitor Pelitinib, Purity ≥98%
|
|
X23-10-ZQ1044 |
EGFR-HER2 inhibitor WZ3146, Purity ≥98%
|
|
X23-10-ZQ1045 |
EGFR-HER2 inhibitor WZ4002, Purity ≥98%
|
|
X23-10-ZQ1046 |
EGFR-HER2 inhibitor WZ8040, Purity ≥98%
|
|
X23-10-ZQ1047 |
EGFR-HER2 inhibitor AG-1478, Purity ≥98%
|
|
X23-10-ZQ1048 |
EGFR-HER2 inhibitor Arry-380 analog, Purity ≥98%
|
|
X23-10-ZQ1049 |
EGFR-HER2 inhibitor AV-412, Purity ≥98%
|
|
X23-10-ZQ1050 |
EGFR-HER2 inhibitor PF299804, Purity ≥98%
|
|
X23-10-ZQ1051 |
EGFR-HER2 inhibitor XL647, Purity ≥98%
|
|
X23-10-ZQ1052 |
EGFR-HER2 inhibitor AST-1306, Purity ≥98%
|
|
X23-10-ZQ1053 |
EGFR-HER2 inhibitor ARRY334543, Purity ≥98%
|
|
X23-10-ZQ1054 |
EGFR-HER2 inhibitor BMS 599626, Purity ≥98%
|
|
X23-10-ZQ1055 |
EGFR-HER2 inhibitor TAK-285, Purity ≥98%
|
|
X23-10-ZQ1056 |
EGFR-HER2 inhibitor BMS-690514, Purity ≥98%
|
|
X23-10-ZQ1057 |
EGFR-HER2 inhibitor BIBX 1382, Purity ≥98%
|
|
X23-10-ZQ1058 |
EGFR-HER2 inhibitor Canertinib dihydrochloride, Purity ≥98%
|
|
X23-10-ZQ1059 |
EGFR-HER2 inhibitor Erlotinib, Purity ≥98%
|
|
X23-10-ZQ1060 |
EGFR-HER2 inhibitor SU-5402, Purity ≥98%
|
|
X23-10-ZQ1061 |
EGFR-HER2 inhibitor Lapatinib (free base), Purity ≥98%
|
|
X23-10-ZQ1062 |
EGFR-HER2 inhibitor AG-17, Purity ≥98%
|
|
X23-10-ZQ1063 |
EGFR-HER2 inhibitor (-)-Gallocatechin, Purity ≥98%
|
|
X23-10-ZQ1065 |
EGFR-HER2 inhibitor CHMFL-EGFR-202, Purity ≥98%
|
|
X23-10-ZQ1066 |
EGFR-HER2 inhibitor EGFR-IN-2, Purity ≥98%
|
|
X23-10-ZQ1067 |
EGFR-HER2 inhibitor PKC 412, Purity ≥98%
|
|
X23-10-ZQ353 |
EGFR-HER2 inhibitor AG-490, Purity ≥98%
|
|
X23-10-ZQ429 |
EGFR-HER2 inhibitor WHI-P 154, Purity ≥98%
|
|